PHASE I SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR PF-06747775 IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要